A difficult-to-treat form of childhood leukemia relies on changes in the structure of DNA — so-called epigenetic changes — to wreak genomic havoc within white blood cells, according to one of two new studies. Researchers also showed that a new drug that blocks these changes could deactivate cancer-promoting genes and halt the growth of this cancer.